ESH/LinkedIn
Apr 27, 2026, 15:38
Key Insights from ESHMPN 26 on Advances in MPN Management – ESH
The European School of Haematology (ESH) shared a post on LinkedIn:
“Today’s second ESHMPN 26 session chaired by Jean – Jacques Kiladjian (INSERM) focussed on MPN management.
Marta Sobas (Collegium Medicum Uniwersytetu Mikołaja Kopernika) on the role of interferons on haematological and molecular responses;
- Jennifer O’Sullivan (Guy’s and St Thomas’ NHS Foundation Trust) on new potential trial endpoints;
- Chloé James (CHU de Bordeaux) on how to prevent thrombosis and bleeding in MPN;
- Selected brief oral presentation by Chiara Carretta, (Centro di Medicina Estetica e Rigenerativa) on determinants of JAK inhibitor efficacy in myelofibrosis revealed by Multiomic Single-Cell Analysis
Stay tuned!
For a deeper insight, meet Marta Sobas, Jennifer O’Sullivan, or Chloé James at tomorrow’s meeting the expert session!”

Stay updated with Hemostasis Today.
-
Aug 10, 2026, 14:52Mohammed Maher Babiker: When Anaemia and Thrombocytopenia Occur Together
-
Aug 10, 2026, 14:38Eloïse Laouenan: Closing ISTH 2026 with Two Outstanding Research Presentations
-
Aug 10, 2026, 14:30Erik Rafflenbeul: Preventing the Need for Coronary Stenting
-
Aug 10, 2026, 14:26Tabassum Rahman: Aboriginal Women’s Voices in Cardiovascular Health Research
-
Aug 10, 2026, 14:01Your Diagnosis Does Not Define Your Future – Glanzmann’s Research Foundation
-
Aug 10, 2026, 13:36Ianalumab and the Changing Landscape of ITP Treatment – ITP Support Association
-
Aug 10, 2026, 13:06Azin Kheirkhah: New Research on OSE-IgM Antibodies and Age-Related Macular Degeneration
-
Aug 10, 2026, 11:20Jean-Jacques Kiladjian: Interferon-Alpha in Polycythemia Vera Balancing Efficacy and Autoimmune Risk
-
Aug 10, 2026, 11:19Rishdha Roshad: Hemodilution vs Transfusion on CPB – Balancing Oxygen Delivery and Microcirculatory Flow